Azmiro TM (testosterone cypionate) is now available in a prefilled syringe formulation for testosterone replacement therapy in males for conditions associated with a deficiency or absence of ...
CUPID (64Cu-TLX592 phase I PK, biodistribution and dosimetry): A proof-of-concept study of TLX592-targeted alpha therapy in prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results